Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
Hives (urticaria) are itchy, raised welts that appear suddenly and often move around the body, fading in one spot while erupting in another. Most cases are driven by histamine released from mast cells in the skin, which is why antihistamines are the foundation of treatment. Choosing the right one, and knowing when a higher dose is appropriate, makes a meaningful difference in comfort and control.
Guidelines across dermatology and allergy consistently recommend a second-generation (non-sedating) H1 antihistamine as first-line therapy for both acute and chronic hives. The common options include:
These are preferred because they cross into the brain far less than older drugs, so they cause much less drowsiness and impairment. They are taken on a scheduled daily basis rather than only when welts appear. Continuous dosing prevents mast cell mediators from gaining the upper hand, and as-needed use tends to leave people chasing symptoms.
First-generation antihistamines such as diphenhydramine (Benadryl), hydroxyzine, and chlorpheniramine are effective at blocking histamine but carry significant sedation, cognitive slowing, and anticholinergic effects such as dry mouth, blurred vision, constipation, and urinary retention. They also wear off in 4 to 6 hours, which makes steady control difficult. Modern guidelines specifically advise against routine use of first-generation agents for hives. They are reserved for limited situations, such as a single nighttime dose when itching prevents sleep, and they are avoided in older adults because of fall risk and cognitive effects.
When a standard once-daily dose does not control symptoms after one to two weeks, international guidelines endorse increasing the dose of the same second-generation antihistamine up to four times the standard amount. In practice:
This approach is well studied and generally better tolerated than adding multiple different drugs. Importantly, dose escalation should be done under medical guidance, because tolerability varies, sedation can emerge at higher doses of cetirizine and levocetirizine, and kidney or liver function may affect safe limits.
Switching to a different second-generation agent is another reasonable step, since individual response varies considerably. Some people respond much better to f
Which Antihistamine for Hives—and When to Raise the Dose
Hives (urticaria) are itchy, red welts on the skin that can vary in size and shape. They often appear and disappear over hours and may recur over days or weeks. Antihistamines are the first-line treatment for most people with hives. This guide explains:
Always speak with a healthcare provider about any serious or life-threatening symptoms. For non-emergency guidance, you might consider a free, online symptom check using the doctor-approved Ubie Symptom Checker.
Key benefits of modern (second-generation) antihistamines:
• Cetirizine
• Typical adult dose: 10 mg once daily
• Onset in 1–2 hours; lasts 24 hours
• May cause mild drowsiness in sensitive individuals
• Loratadine
• Typical adult dose: 10 mg once daily
• Onset in 1–3 hours; lasts 24 hours
• Generally non-sedating
• Fexofenadine
• Typical adult dose: 180 mg once daily (or 60 mg twice daily)
• Onset in 1 hour; lasts 24 hours
• Very low sedation risk
• Desloratadine
• Typical adult dose: 5 mg once daily
• Similar profile to loratadine
• Levocetirizine
• Typical adult dose: 5 mg once daily
• May cause more drowsiness than cetirizine
Dose-escalation strategy (under doctor supervision):
Start with the standard dose of a second-generation antihistamine.
If symptoms remain bothersome after 1–2 weeks, double the daily dose.
If needed, increase up to four times the standard dose (for most drugs):
Monitor for side effects—especially sedation and dry mouth.
Note: Dose-escalation is off-label for some medications. Always do this under medical guidance.
Use these sparingly—usually short-term or as an add-on only at bedtime.
• Pregnancy & Breastfeeding
– Loratadine and cetirizine have more pregnancy safety data
– Always discuss risks vs. benefits with your healthcare provider
• Kidney or Liver Impairment
– Dose adjustments may be needed, especially for cetirizine and levocetirizine
– Fexofenadine largely unchanged by the liver—often safer in liver disease
• Elderly
– Avoid first-generation antihistamines due to fall risk and confusion
– Start at the lower end of dosing ranges
• Adding a leukotriene receptor antagonist (e.g., montelukast)
• A short course of low-dose oral corticosteroids (for severe flares)
• Biologic therapy (e.g., omalizumab) for chronic spontaneous urticaria
Seek immediate medical attention (call 911 or your local emergency number) if you experience:
For non-emergencies, you might consider a free, online symptom check using the doctor-approved Ubie Symptom Checker.
Remember, while antihistamines help many people with hives, treatment needs vary. Speak to a doctor about any serious or life-threatening concerns. If you’re unsure about your symptoms or the right dose, consider a free, online symptom check using the doctor-approved Ubie Symptom Checker.
(References)
* Webb LM, Mikita CP. Solar urticaria. Allergy Asthma Proc. 2009 Sep-Oct;30(5):563-5. doi: 10.2500/aap.2009.30.3273. PMID: 19843410.
* Spickett G. Urticaria and angioedema. J R Coll Physicians Edinb. 2014;44(1):50-4. doi: 10.4997/JRCPE.2014.112. PMID: 24995449.
* Greiwe J, Bernstein JA. Therapy of antihistamine-resistant chronic spontaneous urticaria. Expert Rev Clin Immunol. 2017 Apr;13(4):311-318. doi: 10.1080/1744666X.2017.1249467. Epub 2016 Nov 3. PMID: 27744711.
* Schaefer P. Acute and Chronic Urticaria: Evaluation and Treatment. Am Fam Physician. 2017 Jun 1;95(11):717-724. PMID: 28671445.
* Szymanski K, Schaefer P. Urticaria and Angioedema. Prim Care. 2023 Jun;50(2):237-252. doi: 10.1016/j.pop.2022.11.003. Epub 2023 Mar 2. PMID: 37105604.
* Szymanski K, Schaefer P. Update on Urticaria and Angioedema. Med Clin North Am. 2024 Jul;108(4):687-702. doi: 10.1016/j.mcna.2023.08.004. PMID: 38816111.
* Kolkhir P, Bonnekoh H, Metz M, Maurer M. Chronic Spontaneous Urticaria: A Review. JAMA. 2024 Nov 5;332(17):1464-1477. doi: 10.1001/jama.2024.15568. PMID: 39325444.
* Karlová I. Chronic spontaneous urticaria, treatment with antihistamines. Ceska Slov Farm. 2024;73(1):13-15. doi: 10.36290/csf.2024.002. PMID: 39932020.
* Kostara M, Kosmeri C, Kocatürk E, Alvaro-Lozano M, Barbaud A, Tsabouri S. Exploring treatment options for pediatric refractory chronic urticaria. Expert Rev Clin Immunol. 2025 Aug;21(8):991-1001. doi: 10.1080/1744666X.2025.2538897. Epub 2025 Jul 27. PMID: 40702781.
* Bass M, Atkinson L, Shenker BS. Urticaria: Diagnosis and Management. Prim Care. 2025 Sep;52(3):651-659. doi: 10.1016/j.pop.2025.05.010. Epub 2025 Jul 5. PMID: 40835294.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.